Also listed on Bellus Health Cough Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Mar 4, 2034 · High confidence
20-year base term ends Jan 31, 2034
Filed Jul 29, 2015 as application 14/764,404 · Granted Mar 21, 2017
Base term plus 32 days of patent term adjustment (USPTO delay)
Today
2014
2034
Clock starts
Jan 31, 2014
Jan 31, 2014
Term ends
Mar 4, 2034
Mar 4, 2034
Granted
Mar 21, 2017
Mar 21, 2017
base term
patent term adjustment
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
32
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
12
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 32 days past its 20-year base term on prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 31, 2014, when application PCT/CA2014/050062, the earliest non-provisional in its chain, was filed (this one was filed Jul 29, 2015) | Jan 31, 2034 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +32 days, USPTO patent term adjustment record | Mar 4, 2034 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 4, 2034 | High confidence |
This family
| US 9,598,409 | this patent Mar 2034 | Mar 2034 |
| US 9,814,725 | In force Jan 2034 | Jan 2034 |
| US 9,937,185 | In force Jan 2034 | Jan 2034 |
| Application 15/906,230 | Abandoned not computed | not computed |
| Application 16/375,773 | Abandoned not computed | not computed |
| Application 16/736,599 | Abandoned not computed | not computed |
| Application 17/005,238 | Abandoned not computed | not computed |
| Application 17/225,753 | Abandoned not computed | not computed |
8 of 12 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 15, 2020 Reel 54065, frame 193 | Buon, Christophe; Cantin, Louis-david; Hu, Yun-jin; Luo, Xuehong; Tomaszewsky, Miroslaw Jerzy | AstraZeneca Canada Inc. | Assignment of Assignor's Interest |
| Oct 15, 2020 Reel 54065, frame 533 | AstraZeneca Canada Inc. | AstraZeneca AB | Assignment of Assignor's Interest |
| Oct 15, 2020 Reel 54065, frame 668 | AstraZeneca AB | Neomed Institute | Assignment of Assignor's Interest |
| Aug 24, 2022 Reel 60886, frame 325 | Neomed Institute | Bellus Health Cough Inc. | Assignment of Assignor's Interest |
| Aug 9, 2023 Reel 64531, frame 830 | Bellus Health Cough Inc. | Bellus Health Inc. | Merger |
| Aug 9, 2023 Reel 65117, frame 909 | Bellus Health Inc. | 14245563 Canada Inc. | Assignment of Assignor's Interest |
| Jan 19, 2024 Reel 66353, frame 331 | 14245563 Canada Inc. | Id Biomedical Corporation of Quebec | Assignment of Assignor's Interest |
| Jan 19, 2024 Reel 66353, frame 356 | Id Biomedical Corporation of Quebec | GlaxoSmithKline Intellectual Property (No.3) Limited | Assignment of Assignor's Interest |
| Apr 16, 2025 Reel 71351, frame 192 | GlaxoSmithKline Intellectual Property (No.3) Limited | GlaxoSmithKline Intellectual Property (No.3) Limited | Change of Address |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Mar 2034
Term ends Mar 4, 2034. Maintenance fees still fall due before then
Note
The 32 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
11
later US patents cite this one
That is above the median of utility patents granted in 2017 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.